OTC: DHTI
Dalrada Technology Group, Inc.CIK 0000725394 · SIC 7363 · Help Supply Services
Moving the world forward takes bold resolve that turns ideas into actions and builds real-time solutions that positively impact people and the planet. Dalrada Financial Corporation (“Dalrada” or the “Company”) accelerates positive change for current and future generations by harnessing true… About this business →
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade DHTI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed May 21, 2026 (period ending Mar 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
| Description | Three months ended March 31, 2026 | Three months ended March 31, 2025 | Nine months ended March 31, 2026 | Nine months ended March 31, 2025 |
|---|---|---|---|---|
| Revenues | 1,942,865 | 4,092,398 | 8,720,236 | 12,712,133 |
| Revenues related party | 624,239 | 481,878 | 1,205,587 | 1,007,656 |
| Total revenues | 2,567,104 | 4,574,276 | 9,925,823 | 13,719,789 |
| Cost of revenues | 1,786,660 | 3,169,317 | 7,460,304 | 10,316,781 |
| Gross profit | 780,444 | 1,404,959 | 2,465,519 | 3,403,008 |
| Operating expenses: | ||||
| Selling, general and administrative | 4,064,964 | 5,343,732 | 14,642,615 | 18,109,736 |
| Total operating expenses | 4,064,964 | 5,343,732 | 14,642,615 | 18,109,736 |
| Loss from operations | (3,284,520) | (3,938,773) | (12,177,096) | (14,706,728) |
| Other income (expense): | ||||
| Interest expense | (1,053,546) | (298,028) | (2,631,664) | (2,397,642) |
| Interest income | 39 | 17,881 | 5,095 | 58,163 |
| Other expense | (7,747) | (2,034) | (4,317) | (784,959) |
| Gain (loss) on foreign exchange | 19,487 | (1,575) | 20,225 | 70,084 |
| Total other expense, net | (1,041,767) | (283,756) | (2,610,661) | (3,054,354) |
| Loss before taxes | (4,326,287) | (4,222,529) | (14,787,757) | (17,761,082) |
| Provision for Income Taxes | – | – | 26,180 | 7,524 |
| Net loss | (4,326,287) | (4,222,529) | (14,813,937) | (17,768,606) |
| Other comprehensive loss | ||||
| Foreign currency translation | 102,480 | (52,333) | 262,466 | (2,679) |
| Comprehensive loss | (4,223,807) | (4,274,862) | (14,551,471) | (17,771,285) |
| Net income (loss) attributable to noncontrolling interests | 960 | (27,030) | (9,682) | (52,507) |
| Net loss attributable to Dalrada Technology Group Inc. stockholders | (4,327,247) | (4,195,499) | (14,804,255) | (17,716,099) |
| Net loss per common share to Dalrada stockholders basic | (0.04) | (0.05) | (0.14) | (0.19) |
| Net loss per common share to Dalrada stockholders diluted | (0.04) | (0.05) | (0.14) | (0.19) |
| Weighted average common shares outstanding basic | 108,488,220 | 92,934,331 | 108,488,220 | 92,135,080 |
| Weighted average common shares outstanding diluted | 108,488,220 | 92,934,331 | 108,488,220 | 92,135,080 |
Consolidated Balance Sheets (Unaudited)
| Description | March 31, 2026 (Unaudited) | June 30, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 82,625 | 172,787 |
| Restricted cash | 329,307 | 329,307 |
| Accounts receivable, net | 2,386,017 | 2,747,194 |
| Accounts receivable, net related parties | 1,769,289 | 1,093,620 |
| Inventories | 2,720,656 | 2,689,845 |
| Prepaid expenses and other current assets | 662,151 | 708,268 |
| Total current assets | 7,950,045 | 7,741,021 |
| Long-term receivables | 16,544 | 18,261 |
| Long-term receivables related parties | 1,464,132 | 913,036 |
| Property and equipment, net | 900,963 | 1,273,315 |
| Goodwill | 1,526,042 | 1,531,893 |
| Intangible assets, net | 2,814,234 | 3,110,826 |
| Right-of-use asset, net Operating | 2,324,783 | 2,629,794 |
| Right-of-use asset, net related party - Operating | 721,292 | 1,140,749 |
| Total assets | 17,718,035 | 18,358,895 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | 4,429,922 | 4,175,896 |
| Accrued liabilities | 2,657,754 | 1,256,451 |
| Accounts payable and accrued liabilities related parties | 10,523,659 | 3,387,977 |
| Deferred revenue | 1,640,464 | 1,506,686 |
| Notes payable, current portion | 9,143,168 | 3,937,797 |
| Lease Liability, current portion Operating | 903,174 | 899,402 |
| Lease Liability, current portion related - Operating | 605,567 | 578,631 |
| Total current liabilities | 29,903,708 | 15,742,840 |
| Noncurrent payables | ||
| Notes payable, net of current portion | 377,827 | 4,926,416 |
| Notes payable, net of current portion related parties | 6,328,054 | 1,701,415 |
| Contingent consideration | 211,289 | 211,289 |
| Lease Liability, net of current portion Operation | 1,563,870 | 1,850,671 |
| Lease Liability, net of current portion related party - Operating | 155,389 | 614,681 |
| Total liabilities | 38,540,137 | 25,047,312 |
| Commitments and contingencies (Note 12) | ||
| Stockholders’ equity (deficit): | ||
| Series I preferred stock, $0.01 par value, 100,000 shares authorized, 69,965 and 55,759 shares issued and outstanding as of March 31, 2026 and June 30, 2025, respectively | 700 | 558 |
| Series H preferred stock, $0.01 par value, 15,002 shares authorized, issued and outstanding as of March 31, 2026 and June 30, 2025, respectively | 150 | 150 |
| Series G preferred stock, $0.01 par value, 100,000 shares authorized, 10,002 shares issued and outstanding as of both March 31, 2026 and June 30, 2025, respectively | 100 | 100 |
| Series F preferred stock, $0.01 par value, 5,000 shares authorized, issued and outstanding as of both March 31, 2026 and June 30, 2025, respectively | 50 | 50 |
| Common stock, $0.005 par value, 500,000,000 shares authorized, 120,157,113 and 120,157,113 shares issued and outstanding at March 31, 2026 and June 30, 2025, respectively | 600,785 | 600,785 |
| Common stock to be issued | 18,262 | 7,265 |
| Preferred stock to be issued | – | 11,861,578 |
| Additional paid-in capital | 188,527,695 | 176,249,788 |
| Accumulated deficit | (210,137,584) | (195,323,647) |
| Accumulated other comprehensive loss | 111,930 | (150,536) |
| Total Dalrada Technology Group’s stockholders’ equity (deficit) | (20,877,912) | (6,753,909) |
| Noncontrolling interests | 55,810 | 65,492 |
| Total stockholders’ equity (deficit) | (20,822,102) | (6,688,417) |
| Total liabilities and stockholders’ equity | 17,718,035 | 18,358,895 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Description | Nine months ended March 31, 2026 | Nine months ended March 31, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | (14,813,937) | (17,768,606) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 655,136 | 732,073 |
| Stock compensation | 410,224 | 1,647,067 |
| Changes in operating assets and liabilities, net of amounts acquired or assumed in connection with acquisition: | ||
| Accounts receivable | (314,492) | 471,132 |
| Other receivables | 17,109 | 482,624 |
| Inventories | (30,811) | (206,806) |
| Prepaid expenses and other current assets | 29,008 | (99,406) |
| Noncurrent receivables | (549,379) | 26,578 |
| Accounts payable and accrued liabilities related parties | 6,989,461 | 9,440,875 |
| Accounts payable and accrued liabilities | 1,401,303 | (1,449,145) |
| Decrease in Right of Use Asset/Liability | 9,083 | 27,969 |
| Contingent consideration | – | 209,715 |
| Deferred revenue | 133,778 | 341,976 |
| Net cash used in operating activities | (6,063,517) | (6,143,953) |
| Cash flows from investing activities: | ||
| Purchase of property and equipment | – | (287,080) |
| Purchase of intangibles | – | (146,449) |
| Acquisition of business, net of cash | – | (46,269) |
| Net cash used in investing activities | – | (479,798) |
| Cash flows from financing activities: | ||
| Net proceeds (repayments) from related party notes payable | 4,626,639 | 3,903,354 |
| Repayments of notes payable | – | – |
| Net proceeds (repayments) from notes payable | 656,782 | 1,532,573 |
| Additional Paid in Capital | 12,277,907 | 672,554 |
| Stock issued | (11,850,439) | 114,863 |
| Net cash provided by financing activities | 5,710,889 | 6,223,344 |
| Net change in cash and cash equivalents | (352,628) | (400,407) |
| Effect of exchange rate changes on cash | 262,466 | (2,679) |
| Cash and cash equivalents at beginning of period | 502,094 | 501,927 |
| Cash and cash equivalents at end of period | 411,932 | 98,841 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for income taxes | 18,680 | – |
| Cash paid for interest | 1,277,813 | 2,099,614 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Conversion of related party notes and interest into preferred stock | – | 17,243,235 |
| Preferred stock issued pursuant to business combination | – | 4,596,290 |
| Warrants issued pursuant to acquisitions | 17,245 | 11,496 |
| (Decrease) Increase in right-of-use asset and liability | (4,848) | (27,969) |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗
About Dalrada Technology Group, Inc.
Source: Item 1 (Business) from the 10-K filed September 30, 2025. Description as filed by the company with the SEC.
Item 1. Description of Business
Company Overview
Moving the world forward takes bold resolve that
turns ideas into actions and builds real-time solutions that positively impact people and the planet. Dalrada Financial Corporation (“Dalrada”
or the “Company”) accelerates positive change for current and future generations by harnessing true potential and developing
products and services that become transformative innovations.
Dalrada has five business divisions: Genefic,
Dalrada Climate Technology, Dalrada Precision Manufacturing, Dalrada Technologies and Dalrada Corporate. Within
each of these divisions, the Company drives transformative innovation while creating solutions that are sustainable, accessible, and affordable.
Dalrada’s global solutions directly address climate change, gaps in the health care industry, and technology needs that facilitate
a new era of human behavior and interaction and ensure a bright future for the world around us.
Genefic
Genefic delivers advanced health care solutions
with dedicated products, services, and systems. From virus and disease screening capabilities to pharmaceutical goods and holistic wellness
clinics, When the world needs advanced health care, Genefic delivers with ingenuity, accessibility, and affordability. This specialized
division is committed to developing key health products, lifesaving medications and building comprehensive systems to increase capability,
strive to keep people healthy with the goals of improving their quality of life and increasing their longevity– on a global level.
Read full description ↓
Genefic Specialty Pharmacy
(“Genefic Pharmacy”)- Genefic Pharmacy (formerly Genefic Specialty Pharmacy Rx Solutions) is an Alabama-based pharmacy
with more than 30 years of experience in the retail medical and pharmaceutical industries. Genefic Pharmacy specializes in providing expert
care and managing disease states through comprehensive prescription management, education, nursing, and total health solutions. Genefic
Pharmacy maintains pharmacy licenses in all 50 States as well as Washington D.C.
Genefic Infusion Rx-
Genefic Infusion Rx is a Louisiana-based infusion pharmacy which handles all aspects of fluid and medication infusion, via intravenous
or subcutaneous application. Genefic Infusion Rx serves as an essential with healthcare systems, enhancing the infusion process through
efficient authorization and prescription management. Its state-of-the-art compounding facility is led by one of only eight pharmacists
in Louisiana with a sterile compounding board certification, ensuring top-tier precision and quality in medication preparation.
Boost Diagnostics-
Boost Diagnostics (formerly Empower Genomics and Genefic Diagnostics) is Dalrada’s wholly owned diagnostic laboratory subsidiary
which processes molecular diagnostic and antibody tests to support the diagnosis of COVID-19 and the detection of immune response to the
virus. Boost Diagnostics has built up and maintained the testing capacity to handle surges in COVID-19 testing demands. Boost Diagnostics
also offers genetic testing capabilities including Pharmacogenomics, Nutraceutical, Nutrition/Diet DNA and Exercise/Fitness DNA tests.
Dalrada Career Institute
(“DCI”) (aka International Health Group (“IHG”)) - DCI provides highly trained nursing and medical assistants
for hospitals and home health facilities since 2006. DCI’s programs include Licensed Vocational Nurse (“LVN”), Medical
Assistant Program (“MA”), Certified Nursing Assistant (“CNA") and Home Health Aide (“HHA”) training.
1
Dalrada Climate Technology
Dalrada Climate Technology (“DCT”)
is a segment which incapsulates energy services and state-of-the-art technology within the climate sustainability space. DCT employs next-generation
technology and services which enhances clean energy efforts while reducing the world’s carbon footprint. As a premier industrial
heat pump manufacturer, Dalrada delivers innovation and efficiency, building solutions that reduce energy consumption and minimize carbon
footprints, increase operational efficiencies, meet environmental, social, and governance (ESG) goals, and lower energy costs for clients.
Dalrada Technology Limited
(“DTL”) - DTL is a holding company for all United Kingdom and European based Dalrada Climate Technology entities.
Likido Ltd. (“Likido”)
- Likido is an international engineering company developing advanced solutions for the harvesting and recycling of energy. Using its novel,
heat pump systems (patent pending), Likido is working to revolutionize the renewable energy sector with the provision of innovative modular
process technologies to maximize the capture and reuse of thermal energy for integrated heating and cooling applications. With uses across
industrial, commercial and residential sectors, Likido provides cost savings and minimized carbon emissions across global supply chains.
Likido's technologies enable the effective recovery and recycling of process energy, mitigating against climate change and expected enhancement
of quality of life through the provision of low-carbon heating and cooling systems. Likido’s products currently include the
DCT One Heat Pumps (formerly Likido®ONE) and DCT Cryo Chiller. Likido also offers heat pump solutions specifically designed for residential
purposes.
During 2023, the U.S. Government
selected DCT One Series high-performance, low-carbon heat pump for real-world testing in a prestigious clean energy program. The implementation
of the DCT One Series testing is still in process. The expected positive results should not only increase market acceleration and adoption
within the federal government acceptance of groundbreaking eco-friendly technology but should also accelerate adoption within the commercial
building industry.
Dalrada Technology Spain
L.T. (“DTS”)- DTS was established as a Spanish subsidiary of DTL for the expansion of the manufacturing and sale of the
DCT One Series and DCT Cryo Chiller throughout Europe.
Dalrada Energy Services
(“DES”)- DES provides end-to-end comprehensive energy service solutions in a robust commercial capacity. DES helps organizations
meet ESG goals and standards while mitigating negative environmental impacts.
Bothof Brothers Construction
(“Bothof”)- Bothof is a licensed general contractor which provides a wide range of development, construction and design
capabilities and expertise throughout the United States. Through Bothof’s extensive experience in construction and contracting,
the DES division can provide a myriad of additional services to its private and public works customers.
Dalrada Home Corporation
(“Dalrada Home”)- Dalrada Home Corporation was established in February of 2024. Dalrada Home’s cutting-edge sustainability
solutions are designed specifically for residential purposes. Our home heat pumps help us lead the way in providing innovative climate
technology products and services to residential customers.
Grand Entrances- Grand Entrances is a California
based custom door and hardware retail store.
Dalrada Precision Manufacturing
Dalrada Precision Manufacturing creates total
manufacturing solutions that start with the design and development of high-quality machine parts and components, and end with an efficient
global supply chain. This specialized business division can meet today’s high demands and solves industry challenges. Dalrada Precision
Manufacturing is confident that it redefines the critical quality of the world’s top components and responds with in-house research,
design, engineering, and distribution through a highly reliable global supply chain and improved time-to-market capabilities.
2
Dalrada Precision Parts
(“Precision”) - Precision extends the client its engineering and operations team by helping devise unique manufacturing
solutions tailored to their products. Dalrada Precision can enter at any stage of the product lifecycle from concept and design to mass
production and logistics.
Deposition Technologies
(“DepTec”) - DepTec designs, develops, manufactures, and services chemical vapor and physical vapor deposition systems
for the microchip and semiconductor industries.
DepTec has built an impressive
catalogue of precision OEM (Original Equipment Manufacturer) parts for PVD (Physical vapor deposition) systems and the Company’s
refurbished systems which allows clients the option of purchasing the same model of system they’ve been using for decades –but
with significant upgrades and improved efficiencies. Older systems can now operate more reliably with additional control and monitoring
plus longer lifespans. DepTec also has its own PVD and CVD (Chemical Vapor Deposition) systems, EVOS-PVD and EVOS -CVD, which deposits
metals and non-metals for microchips used in almost every standard and specialized microdevices made today and in the future. These systems
can produce a superior film layer utilized in rugged high-stress environment designs.
Ignite I.T. (“Ignite”)
- Ignite is a manufacturer and seller of eco-friendly deep cleaners, parts washers and degreasers that are specially formulated to lift
hydrocarbon-based dirt and grease from virtually all surfaces with minimal effort. Ignite products are non-flammable, non-corrosive, non-toxic,
butyl-free, water-based, and leave a light citrus scent. Ignite is developed for all surfaces suitable for water and meets or exceed the
most stringent industry-testing specifications.
Dalrada Technologies
Dalrada Technologies has worked with some of the
world’s most recognizable companies, providing digital engineering for cutting-edge software systems and offering a host of robust
digital services. This business division connects the world with integrated technology and innovative solutions, delivering advanced capabilities
and error-free results. Dalrada Technologies creates digital products with expert computer information technology and software engineering
services for a variety of technical industries and clients in both B2B and B2C environments.
Prakat (“Prakat”)
- Prakat is an ISO 9001-certified company that provides end-to-end technology services across various industries, improving the value
chain. The Company specializes in test engineering, accessibility engineering, product engineering, application modernization, billing
and revenue management, CRM, and block chain. Prakat provides global customers with software and technology solutions specializing in
Test Engineering, Accessibility Engineering, Product Engineering and Application Modernization.
Dalrada Corporate
Dalrada Corporate covers the activities which
support the entire suite of Dalrada subsidiaries. Dalrada Corporate includes the areas of administration, finance, human resources, legal
advice, information technology, and marketing. It also contains executive management and shareholder-related services.
Research and Development
We spent $0 on research and development activities
during the years ended June 30, 2025, and 2024, respectively. We anticipate that we will incur additional expenses on research and development
over the next 12 months. Our planned expenditures on our operations or a business combination are summarized under the section of this
Annual Report on form 10-K entitled “Management’s Discussion and Analysis of Financial Position and Results of Operations”.
3